Kim SW - Search Results

1

Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO).

Levy B, Barlesi F, Paz-Ares L, Bennouna J, Erman M, Felip E, Isla D, Ryun Kim H, Kim SW, Madelaine J, Molinier O, Özgüroğlu M, Rodríguez Abreu D, Adeniji A, Lorence RM, Voccia I, Chisamore MJ, Riess JW. Levy B, et al. Among authors: kim sw. Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3. Lung Cancer. 2022. PMID: 35257949 Free article. Clinical Trial.

2

Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).

Lee SW, Choi EK, Chung WK, Shin KH, Ahn SD, Kim JH, Kim SW, Suh C, Lee JS, Kim WS, Kim DS, Kim DK, Park SI, Sohn KH. Lee SW, et al. Among authors: kim ds, kim sw, kim dk, kim ws, kim jh. Lung Cancer. 2002 Jul;37(1):65-71. doi: 10.1016/s0169-5002(02)00026-0. Lung Cancer. 2002. PMID: 12057869 Clinical Trial.

3

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.

Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD. Lee SW, et al. Among authors: kim ds, kim ss, kim sw, kim ws, kim wd, kim jh. Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):996-1004. doi: 10.1016/s0360-3016(03)00127-5. Int J Radiat Oncol Biol Phys. 2003. PMID: 12829135 Clinical Trial.

4

Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer.

Kim SW, Suh C, Lee SD, Kim WS, Kim DS, Kim WD, Lee JS. Kim SW, et al. Among authors: kim ds, kim ws, kim wd. Lung Cancer. 2003 Aug;41(2):221-6. doi: 10.1016/s0169-5002(03)00192-2. Lung Cancer. 2003. PMID: 12871786 Clinical Trial.

5

Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.

Kim YS, Yoon SM, Choi EK, Yi BY, Kim JH, Ahn SD, Lee SW, Shin SS, Lee JS, Suh C, Kim SW, Kim DS, Kim WS, Park HJ, Park CI. Kim YS, et al. Among authors: kim ds, kim sw, kim ws, kim jh. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):76-81. doi: 10.1016/j.ijrobp.2004.09.038. Int J Radiat Oncol Biol Phys. 2005. PMID: 15850905 Clinical Trial.

6

Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer.

Chu DT, Kim SW, Kuo HP, Ozacar R, Salajka F, Krishnamurthy S, Damyanov D, Altug S, Reece WH, Wang L. Chu DT, et al. Among authors: kim sw. Lung Cancer. 2007 Jun;56(3):433-43. doi: 10.1016/j.lungcan.2007.01.028. Epub 2007 Mar 7. Lung Cancer. 2007. PMID: 17346847

7

A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer.

Lee DH, Kim SW, Bae KS, Hong JS, Suh C, Kang YK, Lee JS. Lee DH, et al. Among authors: kim sw. Clin Cancer Res. 2007 Oct 15;13(20):6182-6. doi: 10.1158/1078-0432.CCR-07-0534. Clin Cancer Res. 2007. PMID: 17947485 Clinical Trial.

8

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.

Kim JE, Lee DH, Choi Y, Yoon DH, Kim SW, Suh C, Lee JS. Kim JE, et al. Among authors: kim sw. Lung Cancer. 2009 Sep;65(3):351-4. doi: 10.1016/j.lungcan.2008.12.011. Epub 2009 Jan 20. Lung Cancer. 2009. PMID: 19157632

9

Patient attitudes towards chemotherapy and survival: a prospective observational study in advanced non-small cell lung cancer.

Chu DT, Kim SW, Hsu HK, Cok G, Roubec J, Patil S, Damyanov D, West T, Hall B, Altug S. Chu DT, et al. Among authors: kim sw. Lung Cancer. 2009 Nov;66(2):250-6. doi: 10.1016/j.lungcan.2009.01.022. Epub 2009 Mar 4. Lung Cancer. 2009. PMID: 19264374

10

Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group.

Uhm JE, Park BB, Ahn MJ, Lee J, Ahn JS, Kim SW, Kim HT, Lee JS, Kang JH, Cho JY, Song HS, Park SH, Sohn CH, Shin SW, Choi JH, Park K. Uhm JE, et al. Among authors: kim sw, kim ht. J Thorac Oncol. 2009 Sep;4(9):1136-43. doi: 10.1097/JTO.0b013e3181b270a7. J Thorac Oncol. 2009. PMID: 19687764 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,658 results

Search Page

Filters